Shares of 3M opened lower in pre-market trading after the Australian Commonwealth commenced a major legal action against the company and its local subsidiary. The federal government has filed suit in the Federal Court of Australia, naming 3M Australia Pty Ltd and 3M Company, and is seeking in excess of A$2 billion - roughly $1.43 billion USD - in damages tied to per- and polyfluoroalkyl substances (PFAS) contamination linked to aqueous film-forming foam (AFFF) used at 28 defence bases across Australia.
The Commonwealth alleges that 3M withheld material information regarding environmental hazards associated with its firefighting foam, provided misleading assurances about disposal and environmental safety, and failed to fully disclose the dangers the company knew about. Attorney-General Michelle Rowland described the litigation as "the largest legal claim ever brought by the Commonwealth."
3M said it will defend itself in court. The company reiterated that it "has never manufactured PFAS in Australia and ceased sales of the products at issue in Australia around two decades ago." 3M also noted that the Department of Defence continued to use PFAS-containing firefighting foams for nearly two decades longer, a point the company highlighted in its public response to the suit. The company has previously faced PFAS-related litigation in other jurisdictions; in 2023 it reached a US$10.3 billion settlement with American public water providers, a resolution in which it did not admit liability.
The Australian action compounds an already substantial litigation profile for 3M. Legal exposures and potential remediation costs have been persistent investor concerns because unresolved or costly litigation can reduce certainty about future cash flows and returns of capital, even if the company's operating results remain steady.
Market context offered little cushion for the decline. The S&P 500, Dow Jones Industrial Average, and NASDAQ were trading near flat in pre-market, leaving the legal news as the dominant factor influencing the stock's movement. No major macroeconomic data releases or Federal Reserve announcements were identified as contributors to the move in pre-market trading.
Analysts and market participants noted that the sovereign-level nature of the claim elevates its significance. A judgment in favour of the Commonwealth could not only lead to a substantial payout for damages at the 28 bases named in the suit but could also affect how other governments and large public entities approach contamination claims tied to defence or government facilities. It may also shape expectations about how manufacturers account for long-term environmental liabilities associated with chemicals once marketed as safe.
3M's shares were already trading materially below their 52-week high of $177.41 ahead of the announcement. The new lawsuit has the potential to prolong the period of legal uncertainty that has pressured the stock, as investors weigh the likelihood and magnitude of future cash costs tied to PFAS matters.
Investors will be watching the Federal Court proceedings and subsequent developments closely. For now, 3M has signalled its intent to contest the Commonwealth’s claims in court while reiterating its previous statements about product sales and manufacturing in Australia.
Summary
The Australian government has initiated legal proceedings against 3M Company and 3M Australia Pty Ltd in the Federal Court of Australia, seeking more than A$2 billion (about $1.43 billion USD) over PFAS contamination at 28 defence bases. The Commonwealth alleges withholding of information and misleading assurances about environmental safety from 3M. The company said it will defend itself and noted it stopped selling the implicated products in Australia approximately two decades ago. The lawsuit intensifies the company's ongoing litigation exposure and pushed 3M shares lower in pre-market trading while U.S. indices traded near flat.